5 reports

Our Gastrointestinal Portfolio.

  • Gastrointestinal Drug
  • North America
  • Ardelyx, Inc.
  • Astellas Pharma Inc.
  • Ironwood Pharmaceuticals, Inc.

Some of the prominent trends that the market is witnessing include occurrence of serious health issues with excessive usage of saline laxative, growing incidence of gastrointestinal diseases, recent technological developments of Saline Laxative and growth opportunities/ investment oppor

  • Gastrointestinal Drug
  • OTC
  • APAC
  • North America
  • Forecast
  • Gastrointestinal infection

Diarrhea Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Diarrhea Global Clinical Trials Review, H1, 2015" provides an overview of Diarrhea clinical trials scenario. This report provides top line data relating to the clinical trials on Diarrhea. Report includes an overview of trial...

  • Digestive System Disorder
  • Gastrointestinal Drug
  • North America
  • Furiex Pharmaceuticals, Inc.
  • Sanofi S.A.

The usage of opioids and their adverse effects in gastrointestinal practice: a review.

  • Gastrointestinal Drug
  • North America
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Progenics Pharmaceuticals, Inc.

GASTROINTESTINAL (GI) DISORDERS ##. ##. ##.

  • Gastrointestinal Drug
  • Pharmaceutical
  • North America
  • Market Size
  • MicroBiome Therapeutics LLC